Plasma membrane, Surface antigen-like
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 6, no: 1 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A4HS16
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.716 |
CLV_NRD_NRD_1 | 55 | 57 | PF00675 | 0.515 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.651 |
CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.651 |
DEG_SPOP_SBC_1 | 136 | 140 | PF00917 | 0.420 |
DEG_SPOP_SBC_1 | 141 | 145 | PF00917 | 0.402 |
DEG_SPOP_SBC_1 | 163 | 167 | PF00917 | 0.478 |
DEG_SPOP_SBC_1 | 180 | 184 | PF00917 | 0.414 |
DOC_CKS1_1 | 77 | 82 | PF01111 | 0.370 |
DOC_MAPK_gen_1 | 12 | 20 | PF00069 | 0.610 |
DOC_MAPK_gen_1 | 56 | 63 | PF00069 | 0.363 |
DOC_MAPK_MEF2A_6 | 13 | 22 | PF00069 | 0.526 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.468 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 223 | 227 | PF00917 | 0.379 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.367 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.436 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.335 |
DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.465 |
DOC_WW_Pin1_4 | 268 | 273 | PF00397 | 0.448 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.482 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.373 |
LIG_14-3-3_CanoR_1 | 242 | 250 | PF00244 | 0.355 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.490 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.259 |
LIG_FHA_1 | 170 | 176 | PF00498 | 0.459 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.348 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.276 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.371 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.370 |
LIG_LIR_Gen_1 | 253 | 260 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 253 | 259 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 38 | 43 | PF02991 | 0.355 |
LIG_LYPXL_yS_3 | 117 | 120 | PF13949 | 0.371 |
LIG_LYPXL_yS_3 | 40 | 43 | PF13949 | 0.382 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.361 |
LIG_SH2_NCK_1 | 256 | 260 | PF00017 | 0.361 |
LIG_SH2_SRC | 89 | 92 | PF00017 | 0.310 |
LIG_SH2_STAP1 | 204 | 208 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 250 | 254 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 71 | 75 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.355 |
LIG_SH3_1 | 85 | 91 | PF00018 | 0.323 |
LIG_SH3_3 | 108 | 114 | PF00018 | 0.323 |
LIG_SH3_3 | 74 | 80 | PF00018 | 0.410 |
LIG_SH3_3 | 85 | 91 | PF00018 | 0.347 |
LIG_SUMO_SIM_par_1 | 28 | 33 | PF11976 | 0.531 |
LIG_SUMO_SIM_par_1 | 59 | 65 | PF11976 | 0.360 |
LIG_SxIP_EBH_1 | 252 | 262 | PF03271 | 0.370 |
LIG_TYR_ITIM | 115 | 120 | PF00017 | 0.376 |
LIG_TYR_ITIM | 254 | 259 | PF00017 | 0.362 |
LIG_UBA3_1 | 60 | 68 | PF00899 | 0.351 |
MOD_CDC14_SPxK_1 | 9 | 12 | PF00782 | 0.480 |
MOD_CDK_SPxK_1 | 6 | 12 | PF00069 | 0.483 |
MOD_CDK_SPxxK_3 | 6 | 13 | PF00069 | 0.483 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.543 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.463 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.416 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.405 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.338 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.363 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.362 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.368 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.602 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.698 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.640 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.605 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.541 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.685 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.606 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.481 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.426 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.493 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.463 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.431 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.528 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.439 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.443 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.307 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.343 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.370 |
MOD_N-GLC_1 | 237 | 242 | PF02516 | 0.516 |
MOD_N-GLC_2 | 241 | 243 | PF02516 | 0.557 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.337 |
MOD_NEK2_1 | 252 | 257 | PF00069 | 0.376 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.529 |
MOD_OFUCOSY | 190 | 195 | PF10250 | 0.569 |
MOD_OFUCOSY | 221 | 227 | PF10250 | 0.692 |
MOD_PKA_2 | 241 | 247 | PF00069 | 0.321 |
MOD_PKA_2 | 260 | 266 | PF00069 | 0.514 |
MOD_Plk_1 | 45 | 51 | PF00069 | 0.353 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.387 |
MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.464 |
MOD_ProDKin_1 | 268 | 274 | PF00069 | 0.293 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.483 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.377 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.382 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZJ5 | Leptomonas seymouri | 32% | 100% |
A0A3S5H586 | Leishmania donovani | 92% | 100% |
A4H439 | Leishmania braziliensis | 25% | 92% |
A4H446 | Leishmania braziliensis | 30% | 100% |
E9AK03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q9XZY1 | Leishmania major | 79% | 100% |